Alleviate Health Inc.

Based in the US, Alleviate Health Inc. specializes in enhancing participant recruitment for clinical trials through AI-driven workflows, significantly improving engagement and efficiency. Alleviate Health Inc. was founded in 2024 in Durham, US.

The company focuses on utilizing AI to streamline participant recruitment for clinical trials. In its initial phase, the firm has successfully completed one deal and raised USD 4. 3 mn in Seed funding In October 2025, Alleviate Health Inc. raised USD 4.

3 million in seed funding led by new investors Andreessen Horowitz, with participation from other new investors First Harmonic and Alt Capital. Individual investors also participated in the round. The founder's background is not specifically detailed, but the company aims to expand its outreach in clinical research. Alleviate Health specializes in human-in-the-loop AI workflows designed to enhance participant recruitment for clinical trials in various medical fields, including diabetes, depression, and neurology.

The core offering is an AI-driven platform that enables efficient engagement with potential trial participants through personalized conversations, allowing quick responses to inquiries within 10 seconds. This adaptable workflow maximizes conversion rates and minimizes the time healthcare teams spend on participant screening, serving clinical research sites, patient recruitment teams, and healthcare providers across the US. The platform is supported by a library of over 150,000 conversation templates, improving interactions with participants. Alleviate Health generates revenue through a subscription-based model for clinical research organizations and healthcare providers.

Clients engage with the platform on a contractual basis, utilizing AI workflows to optimize participant outreach and screening. Although specific pricing details are not publicly disclosed, the model suggests a tiered approach based on participant engagement or the extent of AI services utilized, focusing on partnerships with research sites and clinical trial coordinators. Following the Seed funding raised in October 2025, Alleviate Health plans to enhance its business reach and bolster research efforts. The company is expected to broaden its market presence, targeting new geographic regions and specific markets for expansion.

Further details on new product launches or timelines have not been provided, but the recent funding will support these initiatives.